chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nauseous, since the Pfizer vaccine was injected into me; Burning sensation in my throat area, almost like heartburn; Feel unwell; Constipated; Gassy; Overly dehydrated, its like no matter how much I hydrate my pallet seems dry; Slight headache; Tired a lot; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 06May2021 at 12:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID vaccine. Concomitant medications were not reported. On 06May2021 at 14:30, since the Pfizer vaccine was injected, the patient was nauseous, had almost like a burning sensation in throat area, almost like heartburn, also felt unwell, constipated and gassy. The patient was overly dehydrated, it's like no matter how much she hydrate her pallet seems dry, had a slight headache on the first day but that went away, was tired a lot. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event nauseous was not recovered whereas burning sensation in throat area, almost like heartburn, feel unwell, constipated, gassy and the overly dehydrated, like no matter how much hydrated pallet seems dry and tired a lot was unknown at the time of report while slight headache was recovered on an unknown date in May2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Minor swelling and complain of pain upper (L) deltoid injection site and numbness and tingling left hand.
received immunization and was fine for the rest of the day, woke up the next day with fever 101.4; was not sick at all before shot;site of shot was swollen, not red, tender to touch, fever lasted 3 days
FATIGUE, sore arm---next day--24hrs.later---severe headache,, muscle aches,joint aches, chills, fever,---ending 33 hours after the vaccination. Sore arm continued for 3 days----then I am FINE---ALL WELL
Information has been received from a registered nurse concerning a 52 year old female co-worker with no known allergies or pertinent medical history who on 15-OCT-2008 was vaccinated with PNEUMOVAX 23. Concomitant therapy included GARDASIL 0.5 ml IM. The registered nurse reported that the patient developed unspecified body aches on 16-OCT-2008 and sinus congestion on 17-OCT-2008 after receiving PNEUMOVAX 23 on 15-OCT-2008. No other symptoms reported. The patient's unspecified body aches and sinus congestion persisted. The patient did not seek treatment. No lab diagnostics were performed. Additional information has been requested.
Administered a Zostavax vaccine to a 62 year old female who has no contraindications to receive the singles vaccine.  She called me at 1:30 pm to tell me she had a "reaction" to the shot. She left here and went to a restaurant, bought an iced tea, got on the interstate and was unable to swallow her drink, she drove to her Dr. office.  She said they gave her Benadryl and they called 911, who observed her for a while and Dr. sent her home. I spoke with LPN who confirmed that the pt did there with c/o SOB. Blood pressure 200/110, 02 sat 98% and gave her 02 and 50mg. oral Benadryl.
Very mild case of chickenpox. Onset Saturday 07/20/02-back, chest, and legs. Sunday 07/21/02-arms. Back 1, chest 3, left side neck 1, right arm 1, left arm 2, right leg 5, left leg 3 and right side face 3. Fever Fri only 101.7 deg. Dx'd at ER by MD 07/21/02 no cough or cold.
The pt developed a fever of 103F, generalized aches and headaches after the 3rd rabies vaccine. She went to ER.
Received booster dose of vaccine mixed with the wrong diluent, sterile water was used as diluent instead of sodium chloride; Received booster dose of vaccine mixed with the wrong diluent, sterile water was used as diluent instead of sodium chloride; Had a sore arm and was exhausted for a couple of days.; Had a sore arm and was exhausted for a couple of days.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558).  A male patient received bnt162b2 (BNT162B2), administration date 19Nov2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for Covid-19 Immunization; Covid-19 vaccine (DOSE 2, MANUFACTURER UNKNOWN), for Covid-19 Immunization. The following information was reported: IMMUNISATION (non-serious), PRODUCT PREPARATION ERROR (non-serious) all with onset 19Nov2021, outcome "unknown" and all described as "Received booster dose of vaccine mixed with the wrong diluent, sterile water was used as diluent instead of sodium chloride"; FATIGUE (non-serious), PAIN IN EXTREMITY (non-serious) all with onset Nov2021, outcome "unknown" and all described as "Had a sore arm and was exhausted for a couple of days.".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101647371 same drug/event different patient
Received VAVIVAX on 6/24/08 mom noted vesicular rash on hands and legs, had low grade fever.
Patient is a 82 y.o. female patient of, MD was hospitalized hospital my care due to bright red bleeding per rectum was found to have respiratory infection with COVID and was treated in hospital remdesivir IV antibiotics steroids oxygen breathing treatment during the stay in the hospital she improved has taken off the oxygen and has been better.  She has improved now her cough is better shortness of breath is better and she has no fever and chills.  And she is being discharged home.  She was seen by Dr. for GI bleed and outpatient colonoscopy will be done.  She is not on anticoagulation.  She has been pleasant cooperative aware of her diagnosis treatment and the plan and she is doing better with the breathing her cough is better she has very low potassium which is better blood pressure is better she has no further anemia she has immunodeficiency syndrome because of the non-Hodgkin's lymphoma she has osteoporosis spinal stenosis COVID-19 and she has improved in many ways.  She feels better cough is better shortness of breath better she no longer needs isolation now and she would be benefit for physical therapy and hoe health has been arranged for her  with HHC.
Systemic: Allergic: Rash Generalized-Medium, Additional Details: Patient had hives on 4/24/21 after receiving vaccine on 4/22/21.
Weakness, flaccid paralysis, dysmetria in upper extremities, areflexia in lower extremities.
Hospitalized;  COVID-19 positive (9.11.21);  fully vaccinated  Admission Date: 9/11/2021 Discharge Date: 9/14/2021;  DISCHARGE DISPOSITION: Home to assistant living facility DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is a 92 yo female who lives in an assisted living facility home. She presented to the ER today with hypoxia secondary to COVID-19. She is requiring 2L's of supplemental oxygen to maintain O2 sats over 90%. Hopsitalist service contacted for admission. We agreed to admit her for an inpatient stay, anticipating greater than a 2 midnight stay. She is vaccinated with the Johnson and Johnson vaccine. She is non-verbal, non-ambulatory at baseline. I spoke with her DPOA, who states patient is DNR. She consents to convalescent plasma should that treatment be indicated. She would like to be contacted prior to placing a central line or starting vasopressors should that become necessary. She did not know when symptoms started. Her chest x-ray shows possible pneumonia. Procalcitonin ordered at the time of admission. Antibiotics held pending results. Some concern for AKI versus CKD. Will bolus 500ml NSS but hold on additional IV fluids at this time as her blood pressure is good and she does not appear overly dry.  We will titrate oxygen to keep O2 Sats over 92%, wean as tolerated. Convalescent plasma not ordered at the time of admission as I could not confirm onset of symptoms.    Patient required 2 L of oxygen on admission.  She received dexamethasone and Remdesivir.  She tolerated medical management well and was able to be weaned off of oxygen.  Her AKI most likely secondary to fluid volume depletion and resolved with IV fluids.  Her vitals remained stable and her inflammatory markers were improving.  She was discharge back to assisted living facility and provided a prescription for dexamethasone 6 mg for 7 days to finish the 10 day course treatment.  Assisted living facility updated on discharge plan including scheduling follow-up with her PCP in 3-5 days, day were agreeable.
Case number PHEH2014US006190 is an initial spontaneous report received from a nurse on 26 Mar 2014. This report refers to a male patient whose age was not reported. His medical history and concomitant medications were not reported. It was reported that he received an intramuscular dose of MENVEO (batch number: not reported) powder component reconstituted with ZOSTAVAX (other manufacturer, batch number: not reported) diluent on 25 Mar 2014. No adverse event was reported following the maladministration.
This spontaneous report was received from a nurse referring to a 66 year old male patient. The patient's pertinent medical history was not reported. The patient had no known allergies. The patient's concurrent conditions included vitamin B12 deficiency, chronic obstructive pulmonary disease (COPD), dementia, gastrooesophageal reflux disease (GERD), high cholesterol, osteoarthritis, osteoporosis and vitamin D deficiency. On 16-FEB-2018, the patient was vaccinated with PNEUMOVAX23 in the left upper arm, lot # N023650 with expiration date 20-MAY-2019, for prophylaxis (dose and route of administration were not reported). Concomitant therapies included ARICEPT, biotin, calcium, CLARITIN, ubidecarenone, fish oil, FOSAMAX, MOBIC, multiple vitamins, omeprazole, ranitidine, red yeast rice extract, vitamin A, TYLENOL, cholecalciferol and zinc. On 16-FEB-2018, the patient was experiencing myalgia all over his upper body. An unspecified treatment was given for the event. No laboratory/diagnostic tests were performed. On 06-MAR-2018, the patient was seen by the physician. At the time of reporting, the outcome of the event was reported as not recovered. The causality assessment between myalgia and PNEUMOVAX23 was not provided.
Pt states he believes his immune system has been affected by anthrax immunizations since 1996.  "Use to get only one cold a year, now I am getting 6 or 7 per year."  Pt has not previously presented to clinic of any of these "colds" and states they did not affect his active duty flying status.  Pt is wanting this subjective effect to be documented.
27y/o with 1 week hx of myalgia/arthralgia, with chest discomfort not associated with position found to have mycarditis likely related to small pox vaccine. Echocardiogram was within normal limits as read by health professional. Pt recieved Motrin and prednisone while inpatient. He can perform ADLs, tolerated PO, and is hemodynamically stable at this time. Cardiology dept with call pt regarding future apt. will be on light limited duty until cardiology sees him with further recommendations. He will be discharged with motrin and prednisone (see med rec discharge).
I got side effects when taken moderne vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I got side effects when taken moderne vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (I got side effects when taken moderne vaccine). At the time of the report, VACCINATION COMPLICATION (I got side effects when taken moderne vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Yellow Fever administered per protocol 8/12/03. Received call AM of 8/14/03 from pt stating had mild fever, flu-like symptoms and sore arm on 8/13/03. Sore arm where vaccine administered-worsened evening of 8/13/03-very warm to touch, reddened, swollen, size of half dollar. Saw physician for different check up on 8/14/03. Thought to be mild cellulitis. Keflex ordered.
the pain came back in 2-3 weeks; pain when the needle was injected, but it was only briefly and was fine afterwards; in a day or two the pain came back. Then the pain was gone after about four days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (in a day or two the pain came back. Then the pain was gone after about four days), PAIN (the pain came back in 2-3 weeks) and VACCINATION SITE PAIN (pain when the needle was injected, but it was only briefly and was fine afterwards) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Diabetes and Osteoarthritis. On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced PAIN (in a day or two the pain came back. Then the pain was gone after about four days). On 22-Apr-2021, the patient experienced VACCINATION SITE PAIN (pain when the needle was injected, but it was only briefly and was fine afterwards). On an unknown date, the patient experienced PAIN (the pain came back in 2-3 weeks). At the time of the report, PAIN (in a day or two the pain came back. Then the pain was gone after about four days) and VACCINATION SITE PAIN (pain when the needle was injected, but it was only briefly and was fine afterwards) had resolved and PAIN (the pain came back in 2-3 weeks) outcome was unknown.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.No concomitant medications were reported.Treatment medications were not provided by the reporter. This case was linked to MOD-2021-213459 (Patient Link).
bad bone infection; This is a spontaneous report from a contactable consumer from a Pfizer-sponsored program. A 57-year-old female patient (Wife) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 04Mar2021 (Lot number was not reported) at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient had a dental work with an implant placed either on the 08Mar2021 or 10Mar2021 of Mar2021 and she now had a "bad bone infection" in Mar2021. She was taking clindamycin hcl but it didn't work and now she was taking metronidazole and Flagyl (Was placed on heavy duty anti-biotics, wanted to know if taking anti-biotics would affect covid vaccine). Her second dose of the vaccine was due 25Mar2021 and she was very hesitant because of this infection and wanted to know if she should delay the second dose. Reporter stated he had not spoken to the oral surgeon since he's not an expert in vaccines and didn't trust what he would have to say. Not clarified if dental work was scheduled before or after vaccine. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
DTAP given left thigh on 02/11/04, pt seen 12/13 with 6x6cm warm, red induration at vaccination site.  No fever, no limping.  Treated with Augmenting for cellulitis.
Information has been received from a medical assistant referring to an unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with doses of improperly stored RECOMBIVAX HB (lot # L044694, expiration date: 04-FEB-2018, route and dose were unknown) (incorrect product storage). The vaccine was excursion to -3.8 degree Centigrade for 113 hours. It was not excursion previously. No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
pt developed  low grade fever and swelling of both testes after the MMRV immunization.Pt was given the immunization on 4/30 2007. Mom tried cold compresses and  the swelling came down. He was brought in for a check up on 5/2/2007. Pt denied h/o trauma  to the groin area. he said he had mild tenderness on examination
She had her first dose of the COVID Vaccine (COVID19 Vaccine by Pfizer) on the February 3rd and February 20th she had a Positive COVID test done; She had a Positive COVID test; This is a spontaneous report from a contactable consumer reported that a female patient received her first dose of the COVID Vaccine bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number not provided), via an unspecified route of administration on 03Feb2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications was not reported. On 20Feb2021 the patient had a Positive COVID test done. And she is scheduled on the 24th for the Second dose. Patient was wondering if she can still get the second dose or she needs to reschedule it.  Outcome of the events were unknown.  Information about Lot/Batch number has been requested.
I experienced nausea and dizziness for the first 2 days. Then a month later tachycardia appeared.
Patient was administered smallpox vaccine, 17 days later she broke out in multiple red papules that were very pruritic.  The papules are on the back, arms, legs, neck.
mom noticed redness and mild swelling at injection site. no warmt at site. mom states pt was warm, tmax unk, no thermometer, but mom gave acetaminophen, relieved. mom states felt swelling "like a bug bite" at injection site. mom states swelling has decreased from initial onset.
Mother called and stated that the site where pt. has received his PREVNAR 13 vaccination was swollen last night and there is a hard nodule. Mother noticed the swelling last night and the swelling appears to be going down today and there are no other symptoms. Mother requested to have a VAERS form filled out.
This spontaneous report was received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. Patients' pertinent medical history and drug reactions or allergies were not reported. On unknown date in 2016, starting on or after 28-JUN-2016, patients were vaccinated with PROQUAD (lot number L040411 and expiration date 13-APR-2017, lot number M010476 and expiration date 01-SEP-2017, albumin status therapy type, dose and route of administration were not reported). Concomitant therapy was not reported. The temperature of excursion was 17.4F and the time frame was 1 hour 30 minutes. There was no previous temperature excursion. It was stated that the call was because of a data logger. No adverse effect was reported. No product quality complaint was involved. This is on of the two reports received from the same reporter. Additional information has been requested.
The pt experienced uncontrolled crying for over 24 hours. Started shortly after the vaccines were given.
Injected 0.5 ml subcutaneous into her right arm; Right arm very painful; A spontaneous report was received from a pharmacist concerning a 40-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and was injected 0.5 ml subcutaneous (SQ) into right arm and right arm very painful.  The patient's medical history was not provided. Concomitant medications reported included birth control (not specified).   On 21 Jan 2021, 'the patient received their first of two planned doses of mRNA-1273 (Lot number: 027L20A) subcutaneously in the right arm for COVID-19 infection.   On 21 Jan 2021, the nurse vaccinator injected 0.5 ml subcutaneously (SQ) into the underside, fatty part, of the patient's right arm, in error. That night, the patient's right arm "hurt like hell" and was very painful. No treatment medications were reported at the time of this report.  Action taken with mRNA-1273 in response to the events was not reported.   The event,  injected 0.5 ml subcutaneous (SQ) into right arm, was resolved on 21 Jan 2021. The outcome of the event, right arm very painful, was not reported.; Reporter's Comments: This report refers to a case of product administration error for mRNA-1273 (Lot number: 027L20A) , where the first dose of the vaccine was administered subcutaneously. The event of Pain in arm was associated with this case of incorrect route of product administration.
covid-19 Treatment; covid-19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Mar2021 as dose 1, single (Lot number: EN6205), in left arm, on 26May2021 as dose 2, single (Lot number: EP6955), in left arm, on 01Oct2021 as dose 3 (booster), single (Lot number: KF8841), in left arm and on 30Apr2022 at 15:15 as dose 4 (booster), single (Lot number: FJ4989) at the age of 63 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing); "osteoarthritis" (unspecified if ongoing); "anxiety" (unspecified if ongoing). No known allergies. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset Jun2022, outcome "unknown" and all described as "covid-19 Treatment". Therapeutic measures were taken as a result of drug ineffective, suspected covid-19.  Clinical course: The patient was taking any other medications/products within 2 weeks of starting COVID-19 treatment. Reported Event: Last dose of Paxlovid was taken Tuesday morning of 28Jun2022 and symptoms of coughing and nasal congestion had nearly completely resolved as of 26Jun2022. On Thursday 30Jun2022, coughing and congestion returned, and lethargy. Coughing is severe when carrying on a conversation, chest feels tight, but cough is not productive. Today, Saturday 2Jul2022, cough and tiredness continue.
Had general soreness in my left arm but around 6:00pm had tingling in left arm and neck and I felt like I was nervous. Woke up this morning had rash on neck that is warm/burns and I'm nervous, jumpy today, since this morning the rash is spreading up neck to chin.
My BCG scar (from 30 years ago) became tender, swollen, red, itchy, and raised this morning (1/23/21).
Thirty minutes post vaccination patient experienced severe muscle pain from shoulder to elbow of left arm. Pt denies any tingling, numbness in fingers or wrist. No pain below elbow.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Medium, Systemic: Shakiness-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Systemic: Weakness-Severe, Additional Details: Patient felt really dizzy and passed out. 911 was called and EMS came to assess the patient. after assessment and vitals, patient was suggested to be taken to hospital for further assessment. Patient was escorted by ems to emergency department